Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy
Clinical trial NCT01353469 · COMPLETED
Trial details
- NCT number
- NCT01353469
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-11-01
- Enrollment
- 485
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.